Panacea Biotec has launched indigenously developed high quality oncology product, CABAPAN (Cabazitaxel Injection), for treatment of metastatic Castration Resistant Prostrate Cancer (mCRPC). The company will produce the drug at its state-of-the-art at Baddi, Himachal Pradesh. Then drug aims to improve accessibility of this treatment for the benefit of patients at an affordable cost.
Leave a Reply